■ MATERIAL WEAKNESS WATCH
Nasdaq · CIK 0001829667

RGC Regencell Bioscience Holdings Ltd

F
35 / 100
Material weaknesses
3
Restatements
0
Auditor changes
1
Late filings
0
Quarters with open weakness
1
Remediations
0
Deductions
65
Remediation credit
0

Trailing 24 months from 2024-11-07. Rubric v1. How this is scored.

Disclosures, in the company's words

  • Material weakness20-F · filed 2026-10-07source filing ↗
    “Lack of segregation of duties for certain key functions due to limited staff and resources.”
  • Material weakness20-F · filed 2026-10-07source filing ↗
    “Lack of internal audit function to establish a formal risk assessment process and internal control framework;”
  • Material weakness20-F · filed 2026-10-07source filing ↗
    “Lack of sufficient skilled staff with U.S. GAAP knowledge and the U.S. Securities and Exchange Commission (the SEC ) reporting knowledge for the purpose of financial reporting as well as the lack in formal accounting policies and procedures manual to ensure proper financial reporting in accordance with U.S. GAAP and SEC reporting requirements”
  • Controls not effective20-F · filed 2026-10-07source filing ↗
    “In our opinion, because of the effect of the material weaknesses described in the following paragraph on the achievement of the objectives of the control criteria, the Company has not maintained effective internal control over financial reporting as of June 30, 2026”
  • Auditor change20-F · filed 2026-10-07 · Item 16Fsource filing ↗
    “The disclosure called for by paragraph (a) of this Item was previously reported in our Form 6-K filed with the SEC on April 17, 2026.”
  • Material weakness20-F · filed 2026-10-07 · Item 15source filing ↗
    “(3) our lack of segregation of duties for certain key functions due to limited staff and resources”
  • Material weakness20-F · filed 2026-10-07 · Item 15source filing ↗
    “(2) our lack of internal audit function to establish a formal risk assessment process and internal control framework”
  • Material weakness20-F · filed 2026-10-07 · Item 15source filing ↗
    “(1) a lack of accounting staff and resources with appropriate knowledge of U.S. GAAP and SEC reporting and compliance requirements”
  • Controls not effective20-F · filed 2026-10-07 · Item 15source filing ↗
    “Based on this assessment, our management has concluded that our internal control over financial reporting was ineffective as of June 30, 2026, due to the material weaknesses in our internal control over financial reporting identified.”
  • Controls not effective20-F · filed 2026-10-07 · Item 15source filing ↗
    “Based on that evaluation, our management has concluded that our disclosure controls and procedures were not effective as of June 30, 2026 because of the material weaknesses in our internal control over financial reporting identified”
  • Material weakness20-F · filed 2026-10-07 · Item 1Asource filing ↗
    “and (3) our lack of segregation of duties for certain key functions due to limited staff and resources.”
  • Material weakness20-F · filed 2026-10-07 · Item 1Asource filing ↗
    “(2) our lack of internal audit function to establish a formal risk assessment process and internal control framework;”
  • Material weakness20-F · filed 2026-10-07 · Item 1Asource filing ↗
    “(1) our lack of sufficient skilled staff with U.S. GAAP knowledge and the U.S. Securities and Exchange Commission (the SEC ) reporting knowledge for the purpose of financial reporting as well as the lack in formal accounting policies and procedures manual to ensure proper financial reporting in accordance with U.S. GAAP and SEC reporting requirements;”

Filings read

Think something here is wrong? Request a correction. Open corrections hide the affected disclosure until resolved.